Both in Biotechnology
Intensity Therapeutics vs Dyadic International
Over the past year INTS returned −78.3% and DYAI returned −66.2%; their daily moves had a correlation of 0.06.
INTS −78.3% DYAI −66.2%Growth of $1, one year, split-adjusted
| Metric | INTS | DYAI |
|---|---|---|
| Price | $3.36 | $0.3650 |
| Market cap | $11.0M | $14.6M |
| Today | −0.59% | +1.39% |
| 1 month | −5.4% | −19.5% |
| 6 months | −35.5% | −52.0% |
| Year to date | −67.2% | −61.2% |
| 1 year | −78.3% | −66.2% |
| Revenue growth (YoY) | — | −0.6% |
| Gross margin | — | −2.4% |
| Net margin | — | −221.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.8× |
| Net cash | $9.5M | -$1.9M |
| Dividend yield | — | — |
| Volatility (60d) | 62.1% | 76.7% |
| Short % of float | 2.9% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).